查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1592004

體外診斷品管市場：按產品、分銷商、應用和最終用戶分類 - 2025-2030 年全球預測

In-Vitro Diagnostics Quality Control Market by Offering (Data Management Solutions, Quality Assurance Services, Quality Control Products), Distributor (OEM, Third-Party Control Manufacturers), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

體外診斷試劑品管市場規模預計2023年為13.7億美元，預計2024年將達14.8億美元，複合年成長率為8.34%，2030年將達24.1億美元。

體外診斷 (IVD)品管是指用於確保在體外進行的診斷測試（例如血液測試和其他實驗室分析）的準確性和可靠性的流程和材料。這個市場的需求在於它在確保測試準確性、減少誤報和漏報以及確保遵守嚴格的監管標準方面發揮關鍵作用。研究應用範圍廣泛，包括臨床實驗室、醫院、學術和研究機構，最終用途包括監測疾病進展、診斷醫療狀況和管理藥物治療。主要成長動力包括慢性病的增加、實驗室自動化程度的提高以及就地檢驗的普及。最近的技術創新，例如將人工智慧整合到分子診斷和品管過程中，提供了新的機遇，特別是隨著個人化醫療需求的增加。為了利用這些機會，公司需要投資研發，為現有和新興的診斷平台開發更複雜、更具適應性的品管解決方案。然而，市場面臨一定的限制和挑戰，例如與品管產品相關的高成本、監管障礙以及不同診斷設備之間缺乏標準化。這些挑戰可能會給中小企業造成進入障礙並阻礙市場成長。儘管存在這些挑戰，為了提高市場滲透率，創新應特別關注具有成本效益的解決方案以及不同製造商設備之間的互通性。總體而言，體外診斷品管市場的特點是技術快速進步和嚴格監督，要求企業不斷適應和創新以保持競爭力。有針對性的研發投資以及策略聯盟和收購可以進一步推動成長並增加這個充滿活力和不斷發展的行業的市場佔有率。

主要市場統計
基準年[2023] 13.7億美元
預測年份 [2024] 14.8億美元
預測年份 [2030] 24.1億美元
複合年成長率（%） 8.34%

市場動態：快速發展的體外診斷品管市場的關鍵市場洞察

供需的動態交互作用正在改變體外診斷的品管市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 慢性病和感染疾病的流行以及體外診斷的需求
    • 對照護現場診斷技術和第三方品管的需求不斷成長
    • 確保診斷設備和服務安全的政府法規
  • 市場限制因素
    • IVD品管服務成本高
  • 市場機會
    • 將智慧品管引入體外診斷藥物的研發活動
    • 矽技術與多項控制技術進步
  • 市場挑戰
    • 體外診斷藥物核准的嚴格規定與不準確之處

波特五力：駕馭體外診斷品管市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解體外診斷試劑品管市場的外部影響

外部宏觀環境因素在塑造體外診斷品管市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解體外診斷試劑品管市場的競爭狀況

對體外診斷品管市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣體外診斷品管市場供應商績效評估

FPNV 定位矩陣是評估體外診斷品管市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 規劃 IVD品管市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，體外診斷品管市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病和感染疾病的流行以及體外診斷的需求
      • 對照護現場診斷技術和第三方品管的需求不斷成長
      • 確保診斷設備和服務安全的政府法規
    • 抑制因素
      • IVD品管服務高成本
    • 機會
      • 旨在為體外診斷引入智慧品管的研發活動
      • 矽技術和多分析物控制的技術進步
    • 任務
      • 體外診斷檢測產品核准的嚴格規定及不準確問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章體外診斷品管市場：透過提供

  • 資料管理解決方案
  • 品質保證服務
  • 品管產品
    • 基於血清/血漿的控制
    • 尿液檢查
    • 基於全血的控制

第7章 體外診斷試劑品管市場（依供應商分類）

  • 製造商
  • 第三方控制廠商
    • 由獨立製造商管理
    • 儀器特定控制

第8章體外診斷品管市場：依應用分類

  • 臨床化學
  • 凝血或止血
  • 血液學
  • 免疫化學
  • 微生物學
  • 分子診斷

第9章 體外診斷試劑品管市場：依最終用戶分類

  • 臨床實驗室
  • 醫院
  • 研究/學術機構

第10章 南北美洲體外診斷試劑品管市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太體外診斷品管市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲體外診斷試劑品管市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 印度子公司獲得ISO13485認證
    • Werfen 完成對 Immucor 的收購
    • EDX 完成對 IVD 產品開發商 Torax Biosciences 的收購
    • 西門子 Healthineers 和 Unilab 開始建立策略合作夥伴關係，共同建造最先進的診斷測試基礎設施，以改善患者照護
    • UL 解決方案擴大了體外診斷的範圍
    • Qiagen 推出用於實驗室自動採樣的 IVD 平台
    • InDevR 籌集 900 萬美元 B 輪資金籌措並與生物梅里埃合作
    • Veranex 收購 Devicia 和 Clarvin，以擴大 IVD 和醫療設備監管、品質和臨床專業知識
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMerieux Inc.
  • CalibreScientific Global Distribution, Inc.
  • Danaher Corporation
  • Devyser AB
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • Fortress Diagnostics
  • Grifols, SA
  • Hologic, Inc.
  • Illumina, Inc.
  • LGC Limited
  • Maine Molecular Quality Controls, Inc.
  • Micro Bio Logics, Inc.
  • Microbix Biosystems Inc.
  • Ortho-Clinical Diagnostics, Inc.
  • Qiagen NV
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Seegene Inc.
  • Siemens AG
  • Streck, Inc.
  • Sun Diagnostics, LLC
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • ZeptoMetrix Corporation
Product Code: MRR-43127F7279E1

The In-Vitro Diagnostics Quality Control Market was valued at USD 1.37 billion in 2023, expected to reach USD 1.48 billion in 2024, and is projected to grow at a CAGR of 8.34%, to USD 2.41 billion by 2030.

In-Vitro Diagnostics (IVD) Quality Control refers to the processes and materials used to ensure accuracy and reliability in diagnostic tests performed outside the living body, such as blood tests and other lab analyses. This market's necessity lies in the critical role it plays in ensuring test accuracy, reducing false positives/negatives, and ensuring compliance with stringent regulatory standards. Applications range across clinical laboratories, hospitals, and academic/research institutions, with an end-use scope extending to monitoring disease progression, diagnosis of medical conditions, and drug therapy management. Key growth drivers include the increasing prevalence of chronic diseases, advancements in laboratory automation, and growing adoption of point-of-care testing. Recent technological innovations like molecular diagnostics and the integration of artificial intelligence in quality control processes offer fresh opportunities, especially as the demand for personalized medicine grows. To capitalize on these opportunities, companies should invest in R&D to develop more sophisticated, adaptive quality control solutions that address both existing and emerging diagnostic platforms. Nevertheless, the market faces certain limitations and challenges, including high costs associated with quality control products, regulatory hurdles, and a lack of standardization across different diagnostic devices. These challenges can hinder market growth by creating barriers to entry for smaller players. Despite these challenges, innovation should particularly focus on cost-effective solutions and interoperability between devices from different manufacturers to enhance market penetration. Overall, the IVD quality control market is characterized by rapid technological advancements and stringent oversight, requiring players to continuously adapt and innovate to maintain their competitive edge. Investment in targeted R&D, coupled with strategic partnerships and acquisitions, can further drive growth and increase market presence in this dynamic and evolving sector.

KEY MARKET STATISTICS
Base Year [2023] USD 1.37 billion
Estimated Year [2024] USD 1.48 billion
Forecast Year [2030] USD 2.41 billion
CAGR (%) 8.34%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In-Vitro Diagnostics Quality Control Market

The In-Vitro Diagnostics Quality Control Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic and infectious diseases and need for in-vitro diagnostics
    • Growing demand for point-of-care diagnostic technologies and third-party quality controls
    • Government regulations to ensure the safety of diagnostics devices and services
  • Market Restraints
    • High cost of IVD quality control services
  • Market Opportunities
    • R&D activities to introduce smart quality control for in-vitro diagnostics
    • Technological advancement in silicon technology and multianalyte controls
  • Market Challenges
    • Stringent regulations for approval of IVD test products and inaccuracy issues

Porter's Five Forces: A Strategic Tool for Navigating the In-Vitro Diagnostics Quality Control Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In-Vitro Diagnostics Quality Control Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In-Vitro Diagnostics Quality Control Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In-Vitro Diagnostics Quality Control Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In-Vitro Diagnostics Quality Control Market

A detailed market share analysis in the In-Vitro Diagnostics Quality Control Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In-Vitro Diagnostics Quality Control Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In-Vitro Diagnostics Quality Control Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In-Vitro Diagnostics Quality Control Market

A strategic analysis of the In-Vitro Diagnostics Quality Control Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Diagnostics Quality Control Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux Inc., CalibreScientific Global Distribution, Inc., Danaher Corporation, Devyser AB, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Fortress Diagnostics, Grifols, S.A., Hologic, Inc., Illumina, Inc., LGC Limited, Maine Molecular Quality Controls, Inc., Micro Bio Logics, Inc., Microbix Biosystems Inc., Ortho-Clinical Diagnostics, Inc., Qiagen N.V., Quidel Corporation, Randox Laboratories Ltd., Seegene Inc., Siemens AG, Streck, Inc., Sun Diagnostics, LLC, Sysmex Corporation, Thermo Fisher Scientific, Inc., and ZeptoMetrix Corporation.

Market Segmentation & Coverage

This research report categorizes the In-Vitro Diagnostics Quality Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Data Management Solutions, Quality Assurance Services, and Quality Control Products. The Quality Control Products is further studied across Serum/Plasma-Based Controls, Urine-Based Controls, and Whole-Blood-Based Controls.
  • Based on Distributor, market is studied across OEM and Third-Party Control Manufacturers. The Third-Party Control Manufacturers is further studied across Independent Manufacturer Controls and Instrument-Specific Controls.
  • Based on Application, market is studied across Clinical Chemistry, Coagulation or Hemostasis, Hematology, Immunochemistry, Microbiology, and Molecular Diagnostics.
  • Based on End-User, market is studied across Clinical Laboratories, Hospitals, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic and infectious diseases and need for in-vitro diagnostics
      • 5.1.1.2. Growing demand for point-of-care diagnostic technologies and third-party quality controls
      • 5.1.1.3. Government regulations to ensure the safety of diagnostics devices and services
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of IVD quality control services
    • 5.1.3. Opportunities
      • 5.1.3.1. R&D activities to introduce smart quality control for in-vitro diagnostics
      • 5.1.3.2. Technological advancement in silicon technology and multianalyte controls
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations for approval of IVD test products and inaccuracy issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. In-Vitro Diagnostics Quality Control Market, by Offering

  • 6.1. Introduction
  • 6.2. Data Management Solutions
  • 6.3. Quality Assurance Services
  • 6.4. Quality Control Products
    • 6.4.1. Serum/Plasma-Based Controls
    • 6.4.2. Urine-Based Controls
    • 6.4.3. Whole-Blood-Based Controls

7. In-Vitro Diagnostics Quality Control Market, by Distributor

  • 7.1. Introduction
  • 7.2. OEM
  • 7.3. Third-Party Control Manufacturers
    • 7.3.1. Independent Manufacturer Controls
    • 7.3.2. Instrument-Specific Controls

8. In-Vitro Diagnostics Quality Control Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Chemistry
  • 8.3. Coagulation or Hemostasis
  • 8.4. Hematology
  • 8.5. Immunochemistry
  • 8.6. Microbiology
  • 8.7. Molecular Diagnostics

9. In-Vitro Diagnostics Quality Control Market, by End-User

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
  • 9.3. Hospitals
  • 9.4. Research & Academic Institutes

10. Americas In-Vitro Diagnostics Quality Control Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific In-Vitro Diagnostics Quality Control Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa In-Vitro Diagnostics Quality Control Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Indian Subsidiary Acquires ISO13485 Certification
    • 13.3.2. Werfen Completes Acquisition of Immucor
    • 13.3.3. EDX Completes Acquisition of IVD Products Developer Torax Biosciences
    • 13.3.4. Siemens Healthineers and Unilabs Launch Strategic Partnership For Latest Diagnostic Testing Infrastructure To Improve Patients' Care
    • 13.3.5. UL Solutions Expands Scope For In Vitro Diagnostics
    • 13.3.6. Qiagen Unveils IVD Platform For Automated Sampling In Laboratories
    • 13.3.7. InDevR Raises $9 Million in Series B Financing and Partners with bioMerieux
    • 13.3.8. Veranex Acquires Devicia and Clarvin, Expanding Regulatory, Quality, and Clinical Expertise for IVD and Medical Devices
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bio-Techne Corporation
  • 6. bioMerieux Inc.
  • 7. CalibreScientific Global Distribution, Inc.
  • 8. Danaher Corporation
  • 9. Devyser AB
  • 10. DiaSorin S.p.A.
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. Fortress Diagnostics
  • 13. Grifols, S.A.
  • 14. Hologic, Inc.
  • 15. Illumina, Inc.
  • 16. LGC Limited
  • 17. Maine Molecular Quality Controls, Inc.
  • 18. Micro Bio Logics, Inc.
  • 19. Microbix Biosystems Inc.
  • 20. Ortho-Clinical Diagnostics, Inc.
  • 21. Qiagen N.V.
  • 22. Quidel Corporation
  • 23. Randox Laboratories Ltd.
  • 24. Seegene Inc.
  • 25. Siemens AG
  • 26. Streck, Inc.
  • 27. Sun Diagnostics, LLC
  • 28. Sysmex Corporation
  • 29. Thermo Fisher Scientific, Inc.
  • 30. ZeptoMetrix Corporation

LIST OF FIGURES

  • FIGURE 1. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET RESEARCH PROCESS
  • FIGURE 2. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET DYNAMICS
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SERUM/PLASMA-BASED CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, FPNV POSITIONING MATRIX, 2023